DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/18b672/bioinorganic_medic) has announced the addition of John Wiley and Sons Ltd's new book "Bioinorganic Medicinal Chemistry" to their offering.
This book gives a comprehensive overview about medicinal inorganic chemistry. Topics like targeting strategies, mechanism of action, Pt-based antitumor drugs, radiopharmaceuticals are covered in detail and offer the reader an in-depth overview about this important topic.
Key Topics Covered:
- Medicinal Inorganic Chemistry: State of the Art, New Trends and a Vision of the Future
- Targeting Strategies for Metal-Based Therapeutics
- Current Status and Mechanisms of Action of Platinum -
- Based Antitumor Drugs
- New Trends and Future Developments in Platinum -
- Based Antitumor Drugs
- Ruthenium and Other Non-Platinum Anticancer Compounds
- The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds
- Gold-Based Therapeutic Agents
- MRI Contrast Agents: State of the Art and New Trends
- Metal-Based Radiopharmaceuticals
- Boron and Gadolinium in Neutron Capture Therapy of Cancer
- Diseases Related to Disorders in the Metabolism of Essential Ions
- Metal Compounds as Enzyme Inhibitors
- Diagnostic Applications of Metal Containing Luminophores
Author:
Enzo Alessio was born in 1958, studied chemistry at the University of Trieste (Italy) and received his Ph D from the University of Ferrara (Italy) in 1989. After a NATO-CNR postdoctoral fellowship with Luigi G. Marzilli at Emory University (Atlanta), he became first Research Associate and then Associate Professor of Inorganic Chemistry at the University of Trieste, where he is now director of the Ph D School in Chemistry. He is co-author of more than 150 publications and 10 patents in the fields of coordination chemistry, metal-based anticancer drugs, and metal-driven construction of supramolecular architectures, in particular multi-chromophore assemblies for photophysical applications.
For more information visit http://www.researchandmarkets.com/research/18b672/bioinorganic_medic